RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Sanika Chirwa to Reverse Transcriptase Inhibitors

Back to Details
This is a "connection" page, showing publications Sanika Chirwa has written about Reverse Transcriptase Inhibitors.
Sanika Chirwa
Connection Strength
0.139
Reverse Transcriptase Inhibitors
  1. Leger P, Chirwa S, Turner M, Richardson DM, Baker P, Leonard M, Erdem H, Olson L, Haas DW. Pharmacogenetics of efavirenz discontinuation for reported central nervous system symptoms appears to differ by race. Pharmacogenet Genomics. 2016 10; 26(10):473-80.
    View in: PubMed
    Score: 0.139
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support